MarketCap
Facebook
X
TelegramPRA Health Sciences, Inc. P/CF Ratio 2011-2026 | PRAH
Annual P/CF Ratio PRA Health Sciences, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 21.8 | 36.4 | 24.5 | 36 | 27.1 | 21.4 | -245 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 36.4 | -245 | -11.1 |
P/CF Ratio of other stocks in the Diagnostics research industry
| Issuer | P/CF Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
26.1 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
-38.7 | - | - | $ 1.31 B |  USA |
 |
Agilent Technologies
A
|
28.3 | $ 136.78 | 1.03 % | $ 41.6 B | USA |
 |
Celcuity
CELC
|
-35 | $ 131.54 | 0.48 % | $ 6.15 B | USA |
|
Akumin
AKU
|
1.15 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
-0.201 | $ 8.94 | -20.11 % | $ 11.9 M | USA |
 |
Castle Biosciences
CSTL
|
7.33 | $ 21.05 | -4.79 % | $ 610 M | USA |
 |
Aspira Women's Health
AWH
|
-0.0975 | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
-0.0826 | - | -61.36 % | $ 2.46 M | USA |
 |
Fulgent Genetics
FLGT
|
-5.18 | $ 18.53 | 1.59 % | $ 570 M | USA |
 |
Biocept
BIOC
|
-0.447 | - | -13.05 % | $ 7.29 M | USA |
 |
Guardant Health
GH
|
-72.7 | $ 129.1 | -3.09 % | $ 16.2 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-47.7 | - | - | $ 562 M |  Britain |
 |
CareDx, Inc
CDNA
|
23.6 | $ 22.85 | 0.66 % | $ 1.22 B | USA |
 |
Chembio Diagnostics
CEMI
|
-0.991 | - | 0.22 % | $ 16.8 M | USA |
 |
ICON Public Limited Company
ICLR
|
9.76 | $ 137.7 | 0.66 % | $ 10.8 B |  Irlanda |
 |
Check-Cap Ltd.
CHEK
|
-0.541 | - | - | $ 9.42 M |  Israel |
 |
Interpace Biosciences
IDXG
|
1.26 | $ 1.7 | -5.56 % | $ 7.52 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-0.162 | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
19.6 | $ 164.56 | 3.69 % | $ 26.2 B | USA |
 |
Lantheus Holdings
LNTH
|
13.1 | $ 99.63 | 0.01 % | $ 6.72 B | USA |
 |
Global Cord Blood Corporation
CO
|
0.495 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
-17.1 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-23.5 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-2.94 | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
-0.551 | - | -11.32 % | $ 2.94 M | USA |
 |
Mettler-Toledo International
MTD
|
29.7 | $ 1 172.79 | 0.8 % | $ 24.2 B |  Schweiz |
 |
NeoGenomics
NEO
|
284 | $ 10.54 | 3.43 % | $ 1.35 B | USA |
 |
Charles River Laboratories International
CRL
|
10.4 | $ 184.03 | 1.48 % | $ 9.12 B | USA |
 |
National Research Corporation
NRC
|
11.9 | $ 19.83 | 0.86 % | $ 444 M | USA |
 |
Enzo Biochem
ENZ
|
-0.00219 | - | -8.98 % | $ 14.8 K | USA |
 |
Natera
NTRA
|
-12.3 | $ 221.06 | 3.33 % | $ 21.8 B | USA |
 |
Medpace Holdings
MEDP
|
18.2 | $ 450.02 | 0.42 % | $ 13 B | USA |
 |
Exact Sciences Corporation
EXAS
|
39.7 | - | - | $ 19.8 B | USA |
 |
Myriad Genetics
MYGN
|
227 | $ 4.0 | -5.33 % | $ 370 M | USA |
 |
Personalis
PSNL
|
-5.75 | $ 11.38 | 3.64 % | $ 1.02 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
26.5 | $ 26.53 | 0.3 % | $ 25.2 B |  Niderland |
 |
Senseonics Holdings
SENS
|
-5.93 | $ 6.77 | 0.74 % | $ 282 M | USA |
 |
QIAGEN N.V.
QGEN
|
12.6 | - | - | $ 10.6 B | Niderland |
 |
Soleno Therapeutics
SLNO
|
44.5 | - | - | $ 2.69 B | USA |
 |
Twist Bioscience Corporation
TWST
|
-32.8 | $ 68.37 | -0.96 % | $ 4.09 B | USA |
 |
Biomerica
BMRA
|
-1.87 | $ 2.39 | -1.74 % | $ 5.49 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
14.6 | $ 262.39 | 0.14 % | $ 21.8 B | USA |
 |
Thermo Fisher Scientific
TMO
|
25.1 | $ 495.61 | 1.73 % | $ 187 B | USA |
 |
Trinity Biotech plc
TRIB
|
-46.3 | $ 0.71 | 1.11 % | $ 255 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
-0.0884 | - | -34.28 % | $ 263 K | Israel |
 |
Neogen Corporation
NEOG
|
17.5 | $ 9.11 | -2.04 % | $ 1.98 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
12.4 | $ 196.0 | -0.16 % | $ 21.8 B | USA |
 |
Invitae Corporation
NVTA
|
-1.04 | - | - | $ 21.2 M | USA |